advertisement

---

Pharmaceutics 10

Showing records 1 to 10 | Display all abstracts in Pharmaceutics

96400 From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment
Dammak A
Pharmaceutics 2021; 13:

---

96300 Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels
Arroyo-García CM
Pharmaceutics 2021; 13:

---

96400 From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment
Huete-Toral F
Pharmaceutics 2021; 13:

---

96300 Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels
Quinteros D
Pharmaceutics 2021; 13:

---

96400 From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment
Carpena-Torres C
Pharmaceutics 2021; 13:

---

96300 Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels
Palma SD; Jiménez de Los Santos CJ
Pharmaceutics 2021; 13:

---

96400 From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment
Martin-Gil A
Pharmaceutics 2021; 13:

---

96300 Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels
Moyano JR
Pharmaceutics 2021; 13:

---

96400 From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment
Pastrana C; Carracedo G
Pharmaceutics 2021; 13:

---

96300 Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels
Rabasco AM; González-Rodríguez ML
Pharmaceutics 2021; 13:

---